Skip to content

Integrated short-term palliative rehabilitation in incurable cancer

Integrated Short-term Palliative Rehabilitation to improve quality of life and equitable care access in incurable cancer: A multi-national randomised controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16705336
Enrollment
340
Registered
2023-04-27
Start date
2023-10-03
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced incurable solid cancer: lung, colorectal, breast, prostate, etc. Cancer

Interventions

The intervention being tested is Integrated Short-term Palliative Rehabilitation. It comprises up to 3 manualised sessions (face to face and/or remotely (via telephone or video-conference) delivered

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older 2. Diagnosis of incurable solid cancer: lung, colorectal, breast, prostate or other, irrespective of timing in relation to any oncology or palliative care treatments 3. Eastern Cooperative Oncology Group performance status 2-3 4. Able to provide informed consent and complete trial assessments in available languages.

Exclusion criteria

Exclusion criteria: 1. Blood cancers: Leukaemia, Lymphoma, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder (MPD), Multiple Myeloma 2. Currently receiving specialist rehabilitation* for their cancer or co-morbidity-related dysfunction, or received within the two weeks prior to consent 3. Clinician rated prognosis of less than 3 months

Design outcomes

Primary

MeasureTime frame
Health related quality of life - Functional Assessment of Cancer Therapy (FACT) General scale at 8 weeks

Secondary

MeasureTime frame
1. Functional Assessment of Cancer Therapy (FACT) General scale at 4 and 16 weeks 2. Disability - World Health Organization Disability Assessment Schedule (WHODAS 2.0) at 8 and 16 weeks 3. Symptoms- Palliative Outcomes Scale – Symptoms (POS-S) at 8 and 16 weeks 4. Goal attainment- Goal attainment scale (GAS-Light) at 8 and 16 weeks 5. Client Service Receipt Inventory at 8 and 16 weeks

Countries

Czech Republic, Denmark, England, France, Italy, Norway, United Kingdom

Contacts

Public ContactSylvia Wilczynska
sylvia.1.wilczynska@kcl.ac.uk+44 (0)20 7848 0532

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026